Alyeska Investment Group
NFH

Alyeska Investment Group’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Alyeska Investment Group’s Portfolio NFH Stock Details NFH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-601,813
Closed -$6.14M – 518
2019
Q3 		$6.13M Hold
601,813
– – 0.09% 203
2019
Q2 		$6.06M Hold
601,813
– – 0.08% 212
2019
Q1 		$5.96M Buy
601,813
+1,813
+0.3% +$17.9K 0.08% 210
2018
Q4 		$5.88M Buy
+600,000
New +$5.81M 0.09% 213

Other funds holding NFH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SVI
Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

Alyeska Investment Group's NFH Position: Q4 2019 in Review

Alyeska Investment Group sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q4 2019, closing a stake of 601,813 shares — an estimated $6.14M sold.

Alyeska Investment Group first reported a position in NFH in Q4 2018 and held it in 4 quarters. The position peaked at $6.13M in Q3 2019. 20 funds tracked by Wall St. Rank hold NFH as of Q4 2019.

  • Alyeska Investment Group reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 601,813 New Frontier Health Corporation Ordinary Shares shares in Q4 2019, an estimated $6.14M.
  • Alyeska Investment Group first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2018 and held it in 4 quarters.
  • Alyeska Investment Group's New Frontier Health Corporation Ordinary Shares position peaked at $6.13M in Q3 2019.
  • 20 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.